EPISODE · May 15, 2025 · 1 MIN
FDA, OpenAI in Talks on AI Drug Review Amid Oversight Concerns
from The Shib and Tell · host Yona Gushiken
The FDA is eyeing AI-powered drug approvals—and OpenAI’s in the mix. With tools like cderGPT on the table, the agency hopes to transform how drugs get reviewed. But the rapid push has stirred debate over transparency, safety, and oversight. Tune in for what this means for healthcare’s AI future.
Embed this episode
NOW PLAYING
FDA, OpenAI in Talks on AI Drug Review Amid Oversight Concerns
0:00
1:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Shib and Tell?
This episode is 1 minute long.
When was this The Shib and Tell episode published?
This episode was published on May 15, 2025.
Can I download this The Shib and Tell episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!